Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer.

Saved in:
Bibliographic Details
Title: Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer.
Authors: Turkoglu E; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye. ezgiturk_90@hotmail.com., Akdag Topal G; Department of Medical Oncology, Tokat State Hospital, Tokat, Türkiye., Yildirim S; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Kinikoglu O; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Sariyar Busery N; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Aydogan M; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Yildiz HS; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Orman S; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Bayramgil A; Department of Medical Oncology, Umraniye Training and Research Hospital, Health Science University, Istanbul, Türkiye., Gunes TK; Department of Medical Oncology, Umraniye Training and Research Hospital, Health Science University, Istanbul, Türkiye., Tunc MA; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Health Science University, Istanbul, Türkiye., Majidova N; Department of Medical Oncology, Vm Maltepe Medical Park Hospital, Istanbul, Türkiye., Isik D; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Kokten S; Department of Pathology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Odabas H; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye., Turan N; Department of MedicalOncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul, Türkiye.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jun; Vol. 211 (3), pp. 743-752. Date of Electronic Publication: 2025 Apr 11.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first